Abstract
The aim of this study was to evaluate the effect of benazepril addition to amlodipine antihypertensive treatment on ankle–foot volume (AFV) and pretibial subcutaneous tissue pressure (PSTP), two objective measures of ankle oedema. A total of 32 mild to moderate essential hypertensives (DBP>90 and <110 mmHg), aged 30–70 years were studied. After a 4-week placebo period, they were randomized to amlodipine 5 mg o.d. or benazepril 10 mg o.d. or amlodipine 5 mg plus benazepril 10 mg o.d. for 4 weeks, according to a crossover design. At the end of the placebo period and of each active treatment period, blood pressure,AFV and PSTP were evaluated. AFV was measured using the principle of water displacement. PSTP was assessed using a system, the subcutaneous pretibial interstitial enviroment with a water manometer. Both amlodipine and benazepril monotherapy significantly reduced SBP (−18.2±4 and −17.8±4 mmHg, respectively, P<0.01 vs baseline) and DBP (−12.1±3 and −11.7±3 mmHg, respectively, P<0.01); the reduction was increased by the combination (−24.2±5 mmHg for SBP, P<0.001 and −16.8±4 mmHg for DBP, P<0.001). Amlodipine monotherapy significantly increased both AFV (+17.1%, P<0.001 vs baseline) and PSTP (+56.6%, P<0.001 vs baseline). As compared to amlodipine alone, the combination produced a less pronounced increase in AFV (+5.5%, P<0.05 vs baseline and P<0.01 vs amlodipine) and PSTP (+20.5%, P<0.05 vs baseline and P<0.01 vs amlodipine). Ankle oedema was clinically evident in 11 patients with amlodipine monotherapy and in three patients with the combination. These results suggest that ACE-inhibitors partially counteract the microcirculatory changes responsible for Ca-antagonists-induced oedema formation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Joint National Committee on Prevention. Detection, evaluation and treatment of high blood pressure: The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413–2446.
OMS/ISH Guidelines Committee. 1999 World Health Organization—International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–183.
Materson BJ et al. Single drug therapy for hypertension in men. N Engl J Med 1993; 328: 914–921.
Sica DA . Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs 1994; 48: 16–24.
Waeber B, Brunner HR . Combination antihypertensive therapy: does it have a role in rational therapy? Am J Hypertens 1997; 10: 131S–137S.
Messerli FH . Combinations in the treatment of hypertension: ACE-inhibitors and Calcium-antagonists. Am J Hypertens 1999; 12: 868–908.
Kaplan NM . Low-dose combination therapy: the rationalization for an ACE inhibitor and a calcium channel blocker in higher risk patients. Am J Hypertens 2001; 14: 8S–11S.
Guazzi MD et al. Calcium channel blockade with nifedipine and angiotensin converting enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 1984; 80: 279–284.
Kuschnir E, Acuna E, Sevilla D . Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg and placebo. Clin Ther 1996; 18: 1213–1223.
Gradman AH et al, for the Enalapril-Felodipine ER Factorial Study Group (1997). Combined enalapril and felodipine extended release (ER) for systemic hypertension. Am J Cardiol 1997; 79: 431–435.
Messerli FH, Oparil S, Feng Z . Comparison of efficacy and side effects of combination therapy of angiotensin converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000; 86: 1182–1187.
Gustafsson D . Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987; 10 (Suppl 1): S121–S131.
Salmasi AM, Belcaro G, Nicolaides AN . Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema. Int J Cardiol 1991; 30: 303–307.
Messerli FH . Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens 2001; 14: 978–979.
Gustafsson D, Grande PO, Borgstrom P, Lindberg L . Effects of calcium antagonists on myogenic and neurogenic control of resistance and capacitance vessels in cat muscle. J Cardiovasc Pharmacol 1988; 12: 413–422.
Pedrinelli R, Dell’Olmo G, Melillo E, Mariani M . Amlodipine, enalapril and dependent leg edema in essential hypertension. Hypertension 2000; 35: 621–625.
van Hamersvelt HW et al. Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention? J Hypertens 1996; 14: 1041–1045.
Lauderer A . Die Gewebspannung in ihren Einfluss anf die Örtliche Blut -vud Lymphbewegung. Leipzig: Fogel FCW, P. 174.
Burch GE, Sodeman WA . The estimation of subcutaneous pressure by direct method. J Clin Invest 1937; 16: 845–850.
Malamani V . Modificazioni della pressione dei tessuti nell’edema provocato. Boll Soc Ital Biol Sper 1947; 23: 125–131.
Malamani V . La pressione dei tessuti. Pavia, Italy: Tipografia Popolare 485, 1957.
Weir M, Rosenberger C, Fink JC . Pilot study to evaluate a water displacement tecnique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyrisine calcium antagonists. Am J Hypertens 2001; 14: 963–968.
Fogari R et al. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind, randomized, parallel-group study. Curr Ther Res 2000; 61: 850–862.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fogari, R., Malamani, G., Zoppi, A. et al. Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 17, 207–212 (2003). https://doi.org/10.1038/sj.jhh.1001533
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001533
Keywords
This article is cited by
-
Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension
Clinical Drug Investigation (2019)
-
Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients
Advances in Therapy (2010)
-
Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin–angiotensin system
Journal of Human Hypertension (2009)
-
Management of cardiovascular risk with RAS inhibitor/CCB combination therapy
Journal of Human Hypertension (2009)
-
Management of Hypertension with the Fixed Combination of Perindopril and Amlodipine in Daily Clinical Practice
American Journal of Cardiovascular Drugs (2009)